Regeneron Pharmaceuticals (REGN) Higher as Sanofi Raises Stake in 20.5%
Tweet Send to a Friend
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) is 5.5% higher today after Sanofi (NYSE: SNY) disclosed in an amended 13D filing that ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
